指南与共识妇科产科

荷兰全国指南在子宫内膜癌患者中检测Lynch综合征的实施评估

Evaluation of a nationwide Dutch guideline to detect Lynch syndrome in patients with endometrial cancer.
指南 / 共识 · Gynecol Oncol · 2021-01-06

荷兰2016年发布全国指南,推荐对70岁以下子宫内膜癌患者常规进行Lynch综合征筛查(LSS),即错配修复蛋白免疫组化染色,必要时补充MLH1甲基化分析。本研究评估该指南实施情况,纳入14家医院2016年6月至2017年6月诊断的70岁以下子宫内膜癌患者,发现LSS覆盖率为90%,但遗传咨询转诊可进一步改善。

要点

  • 70岁以下子宫内膜癌患者LSS覆盖率达90%。
  • 41例(22%)错配修复蛋白表达缺失,25例为MLH1启动子高甲基化。
  • 15例剩余患者中12例讨论遗传咨询,9例接受胚系检测,7例检出致病性变异。

核心结论

  • LSS覆盖率高(90%),但遗传咨询转诊可改善。
  • 妇科医生应了解知晓突变状态的利弊,并需培训与患者讨论。

研究设计与样本

  • 全国性指南实施评估研究,纳入14家医院2016年6月1日至2017年6月1日诊断的70岁以下子宫内膜癌患者。
  • 从全国病理数据库筛选,收集LSS结果及疑似Lynch综合征病例的随访数据。

主要发现

  • 204个肿瘤中183个(90%)进行了LSS。
  • 41例(22%)错配修复蛋白表达缺失,其中25例为MLH1启动子高甲基化。
  • 1例已知致病性MLH1变异。
  • 15例剩余患者中12例讨论遗传咨询,3例拒绝。
  • 9例接受遗传咨询后行胚系检测:2例未检出致病性变异,2例致病性PMS2变异,5例致病性MSH6变异,与免疫组化结果一致。

关键数值与推荐

  • 指南推荐:所有70岁以下子宫内膜癌女性常规进行Lynch综合征筛查。
  • LSS包括错配修复蛋白免疫组化染色,必要时补充MLH1甲基化分析。
  • 检测结果由治疗妇科医生评估,并将符合条件患者转诊至临床遗传学家。

临床怎么用

  • 对70岁以下子宫内膜癌患者常规实施LSS。
  • 妇科医生应评估LSS结果并转诊符合条件患者至遗传咨询。
  • 妇科医生需培训以与患者讨论突变状态的利弊。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In the Netherlands a nationwide guideline was introduced in 2016, which recommended routine Lynch syndrome screening (LSS) for all women with endometrial cancer (EC) <70 years of age. LSS consists of immunohistochemical (IHC) staining for loss of mismatch repair (MMR) protein expression, supplemented with MLH1 methylation analysis if indicated. Test results are evaluated by the treating gynaecologist, who refers eligible patients to a clinical geneticist. We evaluated the implementation of this guideline. METHODS: From the nation-wide pathology database we selected all women diagnosed with EC < 70 years of age, treated from 1.6.2016-1.6.2017 in 14 hospitals. We collected data on the results of LSS and follow up of cases with suspected LS. RESULTS: In 183 out of 204 tumours (90%) LSS was performed. In 41 cases (22%) MMR protein expression was lost, in 25 cases due to hypermethylation of the MLH1 promotor. One patient was known with a pathogenic MLH1 variant. The option of genetic counselling was discussed with 12 of the 15 remaining patients, of whom three declined. After counselling by the genetic counsellor nine patients underwent germline testing. In two no pathogenic germline variant was detected, two were diagnosed with a pathogenic PMS2 variant, and five with a pathogenic MSH6 variant, in concordance with the IHC profiles. CONCLUSION: Coverage of LSS was high (90%), though referral for genetic counselling could be improved. Gynaecologists ought to be aware of the benefits and possible drawbacks of knowing mutational status, and require training in discussing this with their patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Tjalsma AS, Wagner A, Dinjens WNM, et al. Evaluation of a nationwide Dutch guideline to detect Lynch syndrome in patients with endometrial cancer. Gynecol Oncol. 2021. PMID: 33419609. doi:10.1016/j.ygyno.2020.12.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。